Evidence map›Paper›PMID 36519309›Full record

ArticleEpidemiology and infection2022

Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant

M J Isada, M Reist, M C MacKinnon, F C Uhland, K M Young, K Gibbens, E J Parmley, C A Carson

Open access · goldAbstract readScoping Review
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. First Report ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

M J IsadaCentre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, Ontario, Canada.ORCID 0000-0001-9141-1224
M ReistVeterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada.ORCID 0000-0002-4476-8957
M C MacKinnonCentre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, Ontario, Canada.ORCID 0000-0001-8966-2980
F C UhlandCentre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, Ontario, Canada.ORCID 0000-0003-4988-6458
K M YoungPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.ORCID 0000-0002-3171-2575
K GibbensToronto Western Hospital, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0003-0347-9734
E J ParmleyDepartment of Population Medicine, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0003-4526-9524
C A CarsonCentre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, Ontario, Canada.ORCID 0000-0003-2712-0961
Public Health Agency of Canada · CAHealth Canada · CAUniversity Health Network · CAUniversity of Guelph · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CampylobacterCampylobacter InfectionsCampylobacter jejuniQuinolonesAnti-Bacterial AgentsCanadaCost of IllnessDrug Resistance, BacterialFluoroquinolonesHumansAnti-Bacterial AgentsFluoroquinolonesQuinolonesBurden of illnessCampylobacter spp.fluoroquinolone resistancehuman infectionsscoping review

Identifiers

PMID36519309
PMCPMC9980926
OpenAlexW4308918775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.